Synthesis of nanoparticles of cobalt protoporphyrin IX (Co(III)PPIX NPs). Antiradical, cytotoxicity and antibacterial properties

dc.contributor.authorFijałkowski, Piotr
dc.contributor.authorImpert, Olga
dc.contributor.authorPomastowski, Paweł
dc.contributor.authorRafińska, Katarzyna
dc.contributor.authorWalczak-Skierska, Justyna
dc.contributor.authorFijałkowski, Paweł
dc.contributor.authorKatafias, Anna
dc.contributor.authorvan Eldik, Rudi
dc.date.accessioned2026-03-09T19:03:42Z
dc.date.issued2025
dc.description.abstractPorphyrins, composed of a tetrapyrrolic core and various substituents, are highly valued for their photocatalytic, electrochemical, and biochemical properties. Protoporphyrin IX (PPIX) is a heterocyclic organic compound whose porphyrin ring enables the chelation of transition metals, resulting in metalloporphyrins with diverse biological functions. Cobalt protoporphyrin IX (Co(III)PPIX) is known as an inducer of heme oxygenase-1 (HO-1) and has been identified as a potential photosensitiser for use in photodynamic cancer therapy. In this study, Co(III)PPIX nanoparticles (NPs) were synthesised via the antisolvent method. The resulting NPs were thoroughly characterised using FTIR spectroscopy, Raman spectroscopy, UV-Vis spectroscopy, DLS, SEM, and EDX techniques. Furthermore, their biological properties were investigated, including antibacterial activity (against E. coli, S. aureus, and K. pneumoniae), antioxidant activity, and cytotoxicity tests on Caco-2 and L929 cell lines. The antisolvent method allowed for the synthesis of NPs with a hydrodynamic size below 300 nm, and for one sample, below 200 nm, depending on the conditions. Following synthesis, ultrafiltration (UF) was employed to purify the samples by removing particles not involved in NP formation. A comparative study was conducted between samples subjected to UF and those that were not. The results indicate that using UF led to the synthesis of smaller NPs (307.7 vs. 190.2 nm), differences in Raman spectra, and modified biological properties.
dc.description.sponsorshipNCN, nr projektu: 2020/37/B/ST4/01082
dc.identifier.citationRSC Advances, 2025, 15, pp. 36789-36802
dc.identifier.otherDOI: 10.1039/d5ra07110k rsc.li/rsc-advances
dc.identifier.urihttps://repozytorium.umk.pl/handle/item/7308
dc.language.isoeng
dc.rightsAttribution 4.0 Internationalen
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectcobalt protoporphyrin IX
dc.subjectnanoparticles
dc.subjectantiradical properties
dc.subjectDPPH
dc.subjectantibacterial activity
dc.subjectEscherichia coli
dc.subjectStaphylococcus aureus
dc.subjectKlebsiella pneumoniae
dc.subjectantisolvent method
dc.subjectnanocząstki
dc.subjectDLS
dc.subjectzeta potential
dc.subjectmetoda antyrozpuszczalnikowa
dc.subjectnanocząstki kompleksów
dc.titleSynthesis of nanoparticles of cobalt protoporphyrin IX (Co(III)PPIX NPs). Antiradical, cytotoxicity and antibacterial properties
dc.typeinfo:eu-repo/semantics/article

Files

Original bundle

Loading...
Thumbnail Image
Name:
RSC Adv. 2025 15 36789-36802.pdf
Size:
1.2 MB
Format:
Adobe Portable Document Format

License bundle

Loading...
Thumbnail Image
Name:
license.txt
Size:
1.34 KB
Format:
Item-specific license agreed upon to submission
Description:

Collections